Sign in →

Test Code FRDIG Digoxin, Free, Serum


Specimen Required


Patient Preparation: For 12 hours before specimen collection do not take multivitamins or dietary supplements containing biotin (vitamin B7), which is commonly found in hair, skin, and nail supplements and multivitamins.

Collection Container/Tube:

Preferred: Serum gel

Acceptable: Red top

Submission Container/Tube: Plastic vial

Specimen Volume: 1 mL

Collection Instructions:

1. Draw blood 6 to 8 hours after last dose of digoxin.

2. Serum gel tubes should be centrifuged within 2 hours of collection.

3. Red-top tubes should be centrifuged, and the serum aliquoted into a plastic vial within 2 hours of collection.


Forms

If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:

-Cardiovascular Test Request Form (T724)

-Therapeutics Test Request (T831)

Useful For

Evaluating recrudescent (breakthrough) digoxin toxicity in renal-failure patients

 

Assessing the need for more antidigoxin Fab to be administered

 

Deciding when to reintroduce digoxin therapy

 

Monitoring patients with possible digoxin-like immunoreactive factors (DLIFs)

Method Name

Ultrafiltration followed by Electrochemiluminescent Immunoassay

Reporting Name

Digoxin, Free, S

Specimen Type

Serum

Specimen Minimum Volume

0.6 mL

Specimen Stability Information

Specimen Type Temperature Time Special Container
Serum Refrigerated (preferred) 7 days
  Frozen  180 days

Reject Due To

Gross hemolysis Reject

Reference Values

<16 years:

Therapeutic ranges have not been established for patients who are under 16 years of age. In adults, the suggested serum free digoxin therapeutic range is 0.4-0.9 ng/mL.

Toxic concentration: ≥3.0

 

≥16 years:

0.4-0.9 ng/mL   

Toxic concentration: ≥3.0 ng/ mL

Day(s) Performed

Monday through Sunday

Report Available

Same day/1 day

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test has been modified from the manufacturer's instructions. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

80163

LOINC Code Information

Test ID Test Order Name Order LOINC Value
FRDIG Digoxin, Free, S 3562-6

 

Result ID Test Result Name Result LOINC Value
FRDIG Digoxin, Free, S 3562-6